Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer

[1] Bartkowiak K(2010)Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients J Proteome Res 9 3158-3168

[2] Effenberger KE(2009)Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profile J Proteome Res 8 2004-2014

[3] Harder S(2001)Immunocytochemical detection and characterization of individual micrometastatic tumor cells Methods Mol Med 57 67-73

[4] Andreas A(2005)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 1569-1583

[5] Buck F(1982)A prognostic index in primary breast cancer Br J Cancer 45 361-366

[6] Peter-Katalinic J(2013)Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer Clin Cancer Res 19 6438-6449

[7] Pantel K(2011)RB1 and p53 at the crossroad of EMT and triple-negative breast cancer Cell Cycle 10 1563-1570

[8] Brandt BH(2013)Tumor cell dissemination: emerging biological insights from animal models and cancer patients Cancer Cell 23 573-581

[9] Bartkowiak K(2012)Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer Breast Cancer Res 14 R140-6870

[10] Wieczorek M(2009)Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer Cancer Res 69 6865-2942

[1] Bartkowiak K(2010)Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients J Proteome Res 9 3158-3168

[2] Effenberger KE(2009)Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/ progenitor cell protein profile J Proteome Res 8 2004-2014

[3] Harder S(2001)Immunocytochemical detection and characterization of individual micrometastatic tumor cells Methods Mol Med 57 67-73

[4] Andreas A(2005)Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 1569-1583

[5] Buck F(1982)A prognostic index in primary breast cancer Br J Cancer 45 361-366

[6] Peter-Katalinic J(2013)Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer Clin Cancer Res 19 6438-6449

[7] Pantel K(2011)RB1 and p53 at the crossroad of EMT and triple-negative breast cancer Cell Cycle 10 1563-1570

[8] Brandt BH(2013)Tumor cell dissemination: emerging biological insights from animal models and cancer patients Cancer Cell 23 573-581

[9] Bartkowiak K(2012)Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer Breast Cancer Res 14 R140-6870

[10] Wieczorek M(2009)Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer Cancer Res 69 6865-2942